Component

Intact, immunoreactive bromelain in human plasma

Species, preparation, dose and limitations are retained on linked claims.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. After oral bromelain in 19 healthy men, immunoreactive bromelain with retained proteolytic activity was detected in plasma; the estimated half-life was 6-9 hours.

    Experimental context and source evidence
    dose
    Oral multidosing up to 3 g/day
    duration
    Plasma sampling across 3-51 hours
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    evidence_scope
    literature_reviewed; model-specific source-derived curation
    experimental_model
    Nineteen healthy adult men
    limitations
    Only a small absorbed fraction was detected; immunoreactivity and partial activity do not establish a free therapeutic plasma concentration.
    nutrient_topic
    Bromelain chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Bromelain
    organism
    Nineteen healthy adult men
    plain_language
    After oral bromelain in 19 healthy men, immunoreactive bromelain with retained proteolytic activity was detected in plasma; the estimated half-life was 6-9 hours.
    primary_references
    Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. (1997). https://pubmed.ncbi.nlm.nih.gov/9252520/ DOI: 10.1152/ajpgi.1997.273.1.G139
    route
    Oral
    tissue
    Plasma immunoassay, immunoprecipitation and proteolytic activity

    Bromelain: mechanism of action and interactions (2026-09-20) · lines 11–20

    Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · Nineteen healthy adult men · source_derived_draft · unverified_draft

    ## bromelain-oral-absorption After oral bromelain in 19 healthy men, immunoreactive bromelain with retained proteolytic activity was detected in plasma; the estimated half-life was 6-9 hours. Model/species: Nineteen healthy adult men Tissue/system: Plasma immunoassay, immunoprecipitation and proteolytic activity Exposure: Oral multidosing up to 3 g/day Route: Oral Duration: Plasma sampling across 3-51 hours Limits: Only a small absorbed fraction was detected; immunoreactivity and partial activity do not establish a free therapeutic plasma concentration. Primary reference: Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. (1997). https://pubmed.ncbi.nlm.nih.gov/9252520/ DOI: 10.1152/ajpgi.1997.273.1.G139 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards